Fund Holdings — GILEAD SCIENCES, INC.

Total Portfolio Value
$1.79B
Total Bought
$75.30M
Total Sold
$5.07M
Net Transaction
+$70.23M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ARCUS BIOSCIENCES INC(RCUS)31,424,76031,424,7600255,798427,37723.86%+171,579
GALAPAGOS NV(LKFT)16,707,47716,707,4770467,642578,74732.31%+111,105
ARCELLX INC
COMMON STOCK
6,720,8036,720,8030442,565551,77830.80%+109,213
ASSEMBLY BIOSCIENCES INC2,209,4714,505,391+2,295,92040,036115,3386.44%+75,302
MERUS N V452,527452,527023,80342,6052.38%+18,802
TANGO THERAPEUTICS INC(TNGX)4,854,4434,854,443024,85540,7772.28%+15,923
KYVERNA THERAPEUTICS INC(KYTX)4,126,1194,126,119012,66724,7571.38%+12,090
XILIO THERAPEUTICS INC(XLO)9,105,4519,105,45106,1917,6730.43%+1,482
LEAP THERAPEUTICS INC(CYPH)5,319,1485,319,14801,5792,4150.13%+836
BARINTHUS BIOTHERAPEUTICS PL(BRNS)99,4780-99,478930—-93
IKENA ONCOLOGY INC348,5340-348,5344670—-467
KALARIS THERAPEUTICS INC(KLRS)317,7890-317,7898480—-848
ALLOGENE THERAPEUTICS INC1,156,6890-1,156,6891,3070—-1,307
HOOKIPA PHARMA INC1,875,9450-1,875,9452,3540—-2,354
Page 1 of 1
GILEAD SCIENCES, INC. — 13F Holdings — Q3 2025 | TickerTrail